Literature DB >> 8890917

Synergistic antitumor activity of vitamins C and K3 on human urologic tumor cell lines.

M Venugopal1, J M Jamison, J Gilloteaux, J A Koch, M Summers, D Giammar, C Sowick, J L Summers.   

Abstract

A micro-tetrazolium assay was employed to evaluate vitamin C (VC), vitamin K3 (VK3) and vitamin C/vitamin K3 combinations (VC/VK3) for their antitumor activity against eight human urologic tumor cell lines. While the individual vitamins exhibited antitumor activity at high concentrations, co-administration of the vitamins in a VC : VK3 ratio of 100 : 1 potentiated antitumor activity 4- to 61-fold even when exposure times were as short as 1 hour. Administration of exogenous catalase destroyed the antitumor activity of the vitamins and suggested that hydrogen peroxide and perhaps other reactive oxygen species were involved in the antitumor mechanism of these vitamins. Electron micrographs taken in a previous study demonstrated that vitamin treatment damaged mitochondria and may have impaired ATP synthesis. Analysis of cellular ATP and thiol levels as well as DNA and protein synthesis during the first five hours following a one hour VC/VK3 treatment, revealed: a transient increase in ATP production, a substantial decrease in DNA synthesis, an increase in protein synthesis and a decrease in thiol levels. These results suggested that redox cycling of the vitamin combination increased oxidative stress until it surpassed the reducing ability of the cellular thiols and cellular or genetic damage ensued.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8890917     DOI: 10.1016/0024-3205(96)00466-3

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  8 in total

1.  Nucleolar changes and fibrillarin redistribution following apatone treatment of human bladder carcinoma cells.

Authors:  James M Jamison; Jacques Gilloteaux; Laszlo Perlaky; Marc Thiry; Karel Smetana; Deborah Neal; Karen McGuire; Jack L Summers
Journal:  J Histochem Cytochem       Date:  2010-04-12       Impact factor: 2.479

2.  Nitric oxide modulates sodium vitamin C transporter 2 (SVCT-2) protein expression via protein kinase G (PKG) and nuclear factor-κB (NF-κB).

Authors:  Camila Cabral Portugal; Thaísa Godinho da Encarnação; Renato Socodato; Sarah Rodrigues Moreira; Dan Brudzewsky; António Francisco Ambrósio; Roberto Paes-de-Carvalho
Journal:  J Biol Chem       Date:  2011-10-31       Impact factor: 5.157

3.  Serum markers variation consistent with autoschizis induced by ascorbic acid-menadione in patients with prostate cancer.

Authors:  Eduardo Lasalvia-Prisco; Silvia Cucchi; Jesús Vázquez; Eduardo Lasalvia-Galante; Wilson Golomar; William Gordon
Journal:  Med Oncol       Date:  2003       Impact factor: 3.064

4.  alpha-Tocopheryl succinate promotes selective cell death induced by vitamin K3 in combination with ascorbate.

Authors:  M Tomasetti; E Strafella; S Staffolani; L Santarelli; J Neuzil; R Guerrieri
Journal:  Br J Cancer       Date:  2010-03-23       Impact factor: 7.640

5.  Pankiller effect of prolonged exposure to menadione on glioma cells: potentiation by vitamin C.

Authors:  Marina F Vita; Nivedita Nagachar; Dimitrios Avramidis; Zahid M Delwar; Mabel H Cruz; Åke Siden; Kajsa M Paulsson; Juan Sebastian Yakisich
Journal:  Invest New Drugs       Date:  2010-07-13       Impact factor: 3.850

Review 6.  Roles of autophagy induced by natural compounds in prostate cancer.

Authors:  V Naponelli; A Modernelli; S Bettuzzi; F Rizzi
Journal:  Biomed Res Int       Date:  2015-03-03       Impact factor: 3.411

7.  Menadione : sodium orthovanadate combination eliminates and inhibits migration of detached cancer cells.

Authors:  Zahid M Delwar; Ake Siden; Mabel H Cruz; Juan S Yakisich
Journal:  ISRN Pharmacol       Date:  2012-08-17

8.  Effects of Vitamin K3 Combined with UVB on the Proliferation and Apoptosis of Cutaneous Squamous Cell Carcinoma A431 Cells.

Authors:  Shangyuchen Shi; Gang Zheng; Chunsheng Yang; Xi Chen; Qiuyue Yan; Fan Jiang; Xiaojie Jiang; Yong Xin; Guan Jiang
Journal:  Onco Targets Ther       Date:  2019-12-31       Impact factor: 4.147

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.